According to ED treatment guidelines, oral phosphodiesterase type 5 inhibitors (PDE5 inhibitor) are considered first-line therapy.2
Ngokomhlahlandlela wezokwelapha we-ED, uhlobo lwe-phosphodiesterase yomlomo lwe-5 inhibitors (i-PDE5 inhibitor) lubhekwa ukwelashwa kwelayini lokuqala.